0.776  0.008 (1.04%)		11-28 16:00
Open: 0.8 High: 0.82105 Volume: 109,290		Pre. Close: 0.768 Low: 0.751 Market Cap: 61(M)

Short term
Mid term
Targets	6-month :	0.98	1-year :	1.1
Resists	First :	0.84	Second :	0.94
Pivot price	0.78
Supports	First :	0.67	Second :	0.55
MAs	MA(5) :	0.73	MA(20) :	0.78
	MA(100) :	1.03	MA(250) :	1.56
MACD	MACD :	-0.1	Signal :	-0.1
%K %D	K(14,3) :	41.9	D(3) :	32.8
RSI	RSI(14): 49
52-week	High :	2.74	Low :	0.57

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ VNRX ] has closed above bottom band by 47.4%. Bollinger Bands are 27% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	0.82 - 0.82	0.82 - 0.83
Low:	0.74 - 0.75	0.75 - 0.75
Close:	0.77 - 0.78	0.78 - 0.78

VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating samples for more accurate diagnosis; and Nu.Q Discover, a solution to profiling nucleosomes. The company operates Nucleosomics a technology platform for blood test. VolitionRx Limited is based in Austin, Texas.

Mon, 27 Nov 2023
IO Biotech And 2 Other Stocks Under $2 Insiders Are Buying By ... - Investing.com UK

Fri, 17 Nov 2023
Volition Presents at the 5th Annual Congress of the International ... - InvestorsObserver

Tue, 14 Nov 2023
VolitionRx Limited Announces Third Quarter 2023 Financial Results ... - PR Newswire

Wed, 08 Nov 2023
VolitionRx Limited Schedules Third Quarter 2023 Earnings ... - Valdosta Daily Times

Mon, 06 Nov 2023
Ailing Pope Francis meets with European rabbis and condemns ... - Oil City Derrick

Mon, 06 Nov 2023
Volition and VPG Launch Nu.Q® Vet Cancer Test in UK & Ireland - BioSpace

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: AMEX
Sector: Healthcare
Industry: Diagnostics & Research
Shares Out	0 (M)
Shares Float	0 (M)
Held by Insiders	0 (%)
Held by Institutions	0 (%)
Shares Short	0 (K)
Shares Short P.Month	0 (K)

EPS	0
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	0 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	0
PEG Ratio	0
Price to Book value	0
Price to Sales	0
Price to Cash Flow	0

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.